1-8 of 8
Andreas Evdokiou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer

Free
Margaret M. Centenera, Julia S. Scott, Jelle Machiels, Zeyad D. Nassar, Deanna C. Miller, Irene Zinonos, Jonas Dehairs, Ingrid J.G. Burvenich, Giorgia Zadra, Paolo M. Chetta, Clyde Bango, Emma Evergren, Natalie K. Ryan, Joanna L. Gillis, Chui Yan Mah, Terence Tieu, Adrienne R. Hanson, Ryan Carelli, Katarzyna Bloch, Vasilios Panagopoulos, Etienne Waelkens, Rita Derua, Elizabeth D. Williams, Andreas Evdokiou, Anna Cifuentes-Rius, Nicolas H. Voelcker, Ian G. Mills, Wayne D. Tilley, Andrew M. Scott, Massimo Loda, Luke A. Selth, Johannes V. Swinnen, Lisa M. Butler
Journal: Cancer Research
Cancer Res (2021) 81 (7): 1704–1718.
https://doi.org/10.1158/0008-5472.CAN-20-2511
Published: 01 April 2021
View articletitled, ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer
Open the PDF for ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling

Free
Kathleen I. Pishas, Susan J. Neuhaus, Mark T. Clayer, Andreas W. Schreiber, David M. Lawrence, Michelle Perugini, Robert J. Whitfield, Gelareh Farshid, Jim Manavis, Steve Chryssidis, Bronwen J. Mayo, Rebecca C. Haycox, Kristen Ho, Michael P. Brown, Richard J. D'Andrea, Andreas Evdokiou, David M. Thomas, Jayesh Desai, David F. Callen, Paul M. Neilsen
Journal: Cancer Research
Cancer Res (2014) 74 (3): 921–931.
https://doi.org/10.1158/0008-5472.CAN-13-2424
Published: 02 February 2014
View articletitled, Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling
Open the PDF for Nutlin-3a Efficacy in Sarcoma Predicted by Transcriptomic and Epigenetic Profiling in another window
Includes: Supplementary data
Journal Articles

Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases

Free
Liliana Endo-Munoz, Andrew Cumming, Danny Rickwood, Danielle Wilson, Claudia Cueva, Charlotte Ng, Geoffrey Strutton, A. Ian Cassady, Andreas Evdokiou, Scott Sommerville, Ian Dickinson, Alexander Guminski, Nicholas A. Saunders
Journal: Cancer Research
Cancer Res (2010) 70 (18): 7063–7072.
https://doi.org/10.1158/0008-5472.CAN-09-4291
Published: 14 September 2010
View articletitled, Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases
Open the PDF for Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases in another window
Includes: Supplementary data
Journal Articles

Abstract #4556: The histone deacetylase inhibitor, LBH589 blocks osteoclastogenesis, enhances osteoblast activity and reduces tumor burden in bone

Free
Michelle Lee, Agatha Labrinidis, Vasilios Liapis, Shelley Hay, Irene Zinonos, Lisa Butler, Vladimir Ponomarev, David Findlay, Andreas Evdokiou
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4556.
Published: 01 May 2009
View articletitled, Abstract #4556: The histone deacetylase inhibitor, LBH589 blocks osteoclastogenesis, enhances osteoblast activity and reduces tumor burden in bone
Journal Articles

Abstract #1239: Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumor growth and osteolysis in murine models of breast cancer development and progression

Free
Irene Zinonos, Agatha Labrinidis, Vasilios Liapis, Shelley Hay, Michelle Lee, Vladimir Ponomarev, Peter Diamond, Andrew Zannettino, David Findlay, Andreas Evdokiou
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1239.
Published: 01 May 2009
View articletitled, Abstract #1239: Apomab, a fully human agonistic DR5 monoclonal antibody inhibits tumor growth and osteolysis in murine models of breast cancer development and progression
Journal Articles

Abstract #1041: Osteosarcoma metastasis: evidence for ACP5 downregulation and osteoclast involvement

Free
Liliana Endo-Munoz, Andrew Cumming, Claudia Cueva, Charlotte Ng, Geoffrey Strutton, Andreas Evdokiou, Scott Sommerville, Ian Dickinson, Alexander Guminski, Nicholas Saunders
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1041.
Published: 01 May 2009
View articletitled, Abstract #1041: Osteosarcoma metastasis: evidence for ACP5 downregulation and osteoclast involvement
Journal Articles

ACP5 downregulation and absence of osteoclasts predicts progression to metastasis in osteosarcoma

Free
Liliana Endo-Munoz, Andrew Cumming, Daniel Rickwood, Charlotte Ng, Geoffrey Strutton, Ian Cassady, Andreas Evdokiou, Scott Sommerville, Ian Dickinson, Alexander Guminski, Nicholas Saunders
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3684.
Published: 01 May 2008
View articletitled, ACP5 downregulation and absence of osteoclasts predicts progression to metastasis in osteosarcoma
Journal Articles

Apo2l/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Prevents Breast Cancer–Induced Bone Destruction in a Mouse Model

Free
Le Minh Thai, Agatha Labrinidis, Shelley Hay, Vasilios Liapis, Steve Bouralexis, Katie Welldon, Brendon J. Coventry, David M. Findlay, Andreas Evdokiou
Journal: Cancer Research
Cancer Res (2006) 66 (10): 5363–5370.
https://doi.org/10.1158/0008-5472.CAN-05-4386
Published: 16 May 2006
View articletitled, Apo2l/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Prevents Breast Cancer–Induced Bone Destruction in a Mouse Model
Open the PDF for Apo2l/Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Prevents Breast Cancer–Induced Bone Destruction in a Mouse Model in another window